Interestingly, Cer levels in human gliomas are inversely correlated with their malignant progression and poor prognosis, indicating that the malignant features of these tumors may be caused by alterations in ceramide metabolism [25,26,27,28]. This evidence concerns the gene CBLN1 and glioma.